SelenBio On NetCapital

Republished By Plato

Followers: 0

Analytics

Raised to Date: $147,972

Aggregate Commitments $

Total: $' + total_amount_formatted + '

'; return(hover); }, resize: true, smooth : false, verticalGrid: true }); jQuery('#analytics-tabs').on('change.zf.tabs', function(e) { if(jQuery('#deal_basics:visible').length){ totalChart.redraw(); jQuery(window).trigger('resize'); } }); });

Platform

Netcapital

Start Date

10/03/2019

Close Date

04/28/2020

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

Security Type

Equity - Common

Funding Type

RegCF

Series

Seed

Pre-Money Valuation

$19,621,196

Rolling Commitments $

Prior period: $' + weekly_amount_formatted + '

'; return(hover); }, resize: true, smooth : false, verticalGrid: true }); jQuery('#analytics-tabs').on('change.zf.tabs', function(e) { if(jQuery('#investment_momentum:visible').length){ weeklyChart.redraw(); jQuery(window).trigger('resize'); } }); });

Status

Funded

Reporting Date

05/03/2020

Days Remaining

Funded

% of Min. Goal

1,480%

% of Max. Goal

14%

Likelihood of Max

Funded

Avg. Daily Raise

$711

Momentum

Funded

Location

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Business Type

High Growth

SelenBio, a biotechnology company with a post-money valuation of $20.7 million, is raising funds on NetCapital. The company develops an antibacterial technology that prevents the formation of biofilm in dental, medical, industrial, and consumer applications. SelenBio uses a unique selenium-based compound, SELDOX, to keep the applications infection-free. The company was founded by Kenny Gallagher and Karl Doenges. The proceeds of the current crowdfunding round, with a minimum target of $10,000 and a maximum target of $1,070,000, will be used for research & development, operations, completion of current projects, sales & marketing, and compensation for managers. SelenBio is working on multiple projects with excellent traction and has already received the FDA approval for SELDOX.